At PranaX, our name reflects our commitment to explore science-backed wellness and vitality.​

PranaX is a biotechnology company located in Houston, Texas, that has developed proprietary exosome technology and is advancing products and services to promote long-term health and well-being.

Prana, meaning ‘breath’ in Sanskrit, signifies the vital energy that drives life, a concept we chose to embody our mission of advancing wellness through evidence-based innovation.

Licensed Technology
Licensed Technology

Proprietary Technology Licensed from MD Anderson Cancer Center

The license grants PranaX access to a core patent portfolio covering exosome manufacturing, engineering and pursuit of non-cancer therapeutic applications. The technology leverages the first FDA-approved clinical study using mesenchymal stem cell-derived exosomes.

Read about the clinical study
Leadership

Meet the PranaX Team

PranaX is led by pioneering industry experts with decades of experience, dedicated to advancing the field through innovation and a proprietary technology portfolio. 

Dr. Steven J. Greco, PhD

FOUNDER, CHIEF STRATEGY OFFICER
Read Bio

Kenneth Klein, CPA/MBA

CHIEF FINANCIAL OFFICER, FOUNDING TEAM MEMBER
Read Bio

Lance Kelly, B.A.

EXECUTIVE DIRECTOR OF COMMERCIALIZATION
Read Bio

Michael Francis, PhD

MANUFACTURING AND DEVELOPMENT MANAGER
Read Bio

Christine Conley, A.LM/B.S.

HEAD OF QUALITY
Read Bio

Dr. Raghu Kalluri, MD/PhD

SCIENTIFIC CO-FOUNDER, ADVISORY CHAIR
Read Bio

Dr. Valerie LeBleu, MD/PhD, MBA

SCIENTIFIC CO-FOUNDER, ADVISOR
Read Bio